Article Information
History
- September 22, 2022.
Article Versions
- Version 1 (September 17, 2022 - 11:03).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Ana Beatriz C Cazé1,
- Thiago Cerqueira-Silva, MD2,1,
- Adriele Pinheiro Bomfim, M. Sc.4,1,
- Gisley Lima de Souza6,7,
- Amanda Canário Andrade Azevedo, MD, M.Sc.8,
- Michelle Queiroz Aguiar Brasil, MD, M. Sc.7,10,
- Nara Rúbia Santos11,
- Ricardo Khouri, PhD12,7,
- Jennifer Dan, MD, PhD14,15,
- Antonio Carlos Bandeira, Infectious Diseases Advisor, MD, PhD16,17,
- Luciano Pamplona de Goes Cavalcanti, MD, PhD18,19,
- Manoel Barral-Netto, MD, PhD2,1,
- Aldina Maria Prado Barral22,23,
- Cynara Gomes Barbosa, PhD*,24 and
- Viviane Sampaio Boaventura, MD, PhD*,2,1,#
- 1Universidade Federal da Bahia, Salvador, Bahia, Brazil
- 2LIB and LEITV Laboratories, Instituto Gonçalo Moniz, Fiocruz, Salvador, Bahia, Brazil
- 4Instituto Gonçalo Muniz, Fiocruz, Salvador, Brazil
- 6Escola de Medicina e Saúde Pública da Bahia
- 7Instituto Gonçalo Moniz, Fiocruz, Salvador, Bahia, Brazil
- 8Hospital Santa Izabel, Santa Casa da Bahia, Salvador, Bahia, Brazil
- 10Federal University of Bahia, Salvador, Bahia, Brazil
- 11Departamento de Vigilância em Saúde/Vigilância Epidemiológica, Campo Formoso, Bahia Brazil
- 12Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Clinical and Epidemiological Virology, Belgium
- 14Center for Infectious Disease and Vaccine Research, la Jolla Institute for Immunology (LJI)
- 15Department of Medicine, Division of Infectious Disease and Global Public Health, University of California, San Diego (UCSD), La Jolla, CA 92037, USA
- 16UNI-FTC-Faculdade Tecnologia Ciências Medical School, Bahia
- 17Central State Laboratory LACEN-Bahia
- 18Universidade Federal do Ceará, Fortaleza, Ceará, Brazil
- 19Centro Universitario Christus, Fortaleza, Ceará, Brazil
- 22Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Bahia, Brazil
- 23Instituto de Investigação em Imunologia, São Paulo, São Paulo, Brazil
- 24Universidade Federal da Bahia, Salvador, Brazil
- ↵#Corresponding author Viviane Sampaio Boaventura, Email address: vsboaventura{at}gmail.com, Telephone: + 55 71 31762211, Postal address: 121 Waldemar Falcão Street, Candeal, Salvador, Bahia, Brazil, CEP 40296
↵* Those authors equally supervised this study
Posted September 22, 2022.
Prevalence and risk factors for long COVID after mild disease: a longitudinal study with a symptomatic control group
